Loading...
Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies
Biologics to TNF family receptors are prime candidates for therapy of immune disease. Whereas recent studies have highlighted a requirement for Fcγ receptors in enabling the activity of CD40, TRAILR, and GITR when engaged by antibodies, other TNFR molecules may be controlled by additional mechanisms...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Rockefeller University Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4076583/ https://ncbi.nlm.nih.gov/pubmed/24958847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20132687 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|